May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Luteolin or Isoquercetin: Antioxidant Potency and Dietary Effects on Diabetic Rats
Author Affiliations & Notes
  • J.R. Trevithick
    University of Western Ontario, London, ON, Canada
    School of Kinesiology,
  • T.M. Dzialoszynski
    University of Western Ontario, London, ON, Canada
    School of Kinesiology, Thames Hall,
  • M.M. Collins
    University of Western Ontario, London, ON, Canada
    School of Kinesiology, Thames Hall,
  • J. Foster
    University of Western Ontario, London, ON, Canada
    School of Kinesiology, Thames Hall,
  • M. Hirst
    University of Western Ontario, London, ON, Canada
    Physiology and Pharmacology,,
  • S.E. Sanford
    Swine Products, Boehninger–Ingelheim Canada, London, ON, Canada
  • S.E. Sanford
    Swine Products, Boehninger–Ingelheim Canada, Hamilton, ON, Canada
  • Footnotes
    Commercial Relationships  J.R. Trevithick, BDH Canada, Merck Darmstadt, F; T.M. Dzialoszynski, BDH Canada, Merck Darmstadt, F; M.M. Collins, None; J. Foster, None; M. Hirst, BDH Canada, Merck Darmstadt, F; S.E. Sanford, None; S.E. Sanford, None.
  • Footnotes
    Support  BDH Canada/Merck Darmstadt Unconditional grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4122. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.R. Trevithick, T.M. Dzialoszynski, M.M. Collins, J. Foster, M. Hirst, S.E. Sanford, S.E. Sanford; Luteolin or Isoquercetin: Antioxidant Potency and Dietary Effects on Diabetic Rats . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4122.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Luteolin or isoquercetin was used (a) in vitro as an antioxidant and (b) in vivo to determine whether it could reduce damage in model diabetic cataract.

Methods: : For (a), the Inhibitory Concentration for 50 % inhibition (IC50 )of our in vitro antioxidant assay. For (b) cataract grades of streptozotocin diabetic rats fed 0.5% luteolin or isoquercetin were followed every 2 wk for 9 weeks.

Results: : Luteolin or isoquercetin in vitro was an antioxidant when challenged with peroxide. In vivo feeding luteolin or isoquercetin resulted in similar growth and body condition for diabetic rats, and luteolin showed higher cataract grades at 7 weeks than untreated diabetic rats. After 5 and 9 weeks, diabetic rats supplemented with isoquercetin had lower cataract grade, which at 9 weeks only showed a trend to significance (p<0.075). Final serum glucose levels at 9 weeks were not significantly different, but glycohemoglobin A1 levels were significantly lower (60.0 %, p<0.05) in luteolin–fed diabetic rats.

Conclusions: : Luteolin or isoquercetin both are potent antioxidants. Luteolin appears in vivo to have a transient cataract–potentiating effect, but also significantly reduces glycation of proteins, and either luteolin or quercetin decrease (but not significantly) the plasma glucose concentration.

Keywords: diabetes • antioxidants • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×